Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee

A wide variety of new therapeutic options for Multiple Myeloma (MM) have recently become available, extending progression-free and overall survival for patients in meaningful ways. However, these treatments are not curative, and patients eventually relapse, necessitating decisions on the appropriate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Shaji, Baizer, Lawrence, Callander, Natalie S., Giralt, Sergio A., Hillengass, Jens, Freidlin, Boris, Hoering, Antje, Richardson, Paul G., Schwartz, Elena I., Reiman, Anthony, Lentzsch, Suzanne, McCarthy, Philip L., Jagannath, Sundar, Yee, Andrew J., Little, Richard F., Raje, Noopur S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243011/
https://www.ncbi.nlm.nih.gov/pubmed/35768410
http://dx.doi.org/10.1038/s41408-022-00695-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243011/
https://www.ncbi.nlm.nih.gov/pubmed/35768410
http://dx.doi.org/10.1038/s41408-022-00695-5

Ejemplares similares